2 Growth Stocks to Buy Before the Bull Market Arrives

86
Comment
Favorite

2 Growth Stocks to Buy Before the Bull Market Arrives

Motley Fool2023-03-16

Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Tanyl
·2023-03-17
Must invest Nvidia
Reply
2
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2319359390?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-16 20:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2319359390","market":"us","top_or_hot":-1,"title":"2 Growth Stocks to Buy Before the Bull Market Arrives","media":"Motley Fool","content":"<div>\n<p>Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks to Buy Before the Bull Market Arrives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks to Buy Before the Bull Market Arrives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-16 20:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0640476718.USD","symbol_name":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","start_time":0,"source_url":"https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/","article_id":"2319359390","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2319359390","pubTimestamp":1678970199,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Long-term investors shouldn't hesitate to add these stocks to their portfolios.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","BK4503":"景林资产持仓","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","BK4551":"寇图资本持仓","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","LU0109391861.USD":"富兰克林美国机遇基金A Acc","ABBV":"艾伯维公司","BK4529":"IDC概念","BK4534":"瑞士信贷持仓","BK4543":"AI","BK4587":"ChatGPT概念","LU1861215975.USD":"贝莱德新一代科技基金 A2","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","SG9999002224.SGD":"Allianz Global High Payout SGD","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","BK4527":"明星科技股","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0056508442.USD":"贝莱德世界科技基金A2","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","BK4585":"ETF&股票定投概念","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4579":"人工智能","LU2063271972.USD":"富兰克林创新领域基金","BK4554":"元宇宙及AR概念","BK4550":"红杉资本持仓","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","LU0109392836.USD":"富兰克林科技股A","SG9999002232.USD":"Allianz Global High Payout USD","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","BK4549":"软银资本持仓","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","BK4588":"碎股","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","BK4567":"ESG概念","BK4532":"文艺复兴科技持仓","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0082616367.USD":"摩根大通美国科技A（dist）","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","BK4581":"高盛持仓","BK4548":"巴美列捷福持仓","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","BK4023":"应用软件","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","NVDA":"英伟达"},"translate_title":"牛市到来前买入2只成长股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ABBV":0.9,"NVDA":0.9},"content_text":"Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation, you shouldn't wait to buy it. Provided you're willing to buy and hold for years, now may be a good time to buy stocks while valuations are low.A couple of stocks that look particularly good right now include AbbVie (ABBV 0.14%) and Nvidia (NVDA 0.69%). These businesses have promising growth potential, and adding either one of them to your portfolio today could be a great move.1. AbbVieDrugmaker AbbVie makes for both a solid growth stock and an income investment. At 4%, its dividend yield is more than twice the S&P 500 average of 1.7%. What makes it even more attractive is that it's also a Dividend King, with a track record for growing its dividend on a yearly basis. In just five years, its dividend payment has increased by 54%. The company's strong free cash flow and solid financials also suggest that more rate increases could be coming.Fundamental Chart data by YChartsOver the past year, the healthcare stock has fluctuated and is up just a modest 2%. At a forward price-to-earnings (P/E) ratio of 14, which is based on analyst expectations, it's trading well below the S&P 500 average of 18.Investors have probably been discounting AbbVie as a result of the loss in patent protection for its top-selling drug, Humira, which has already begun. But the company's outlook and growth opportunities remain strong; AbbVie has more than 50 programs in its pipeline that are in mid- and late-stage trials that could help the company develop the next blockbuster drug. It has also been heavily investing in research and development, to the tune of $6.5 billion last year.Plus, AbbVie already has a couple of promising immunology treatments with Skyrizi and Rinvoq, which earned a combined $7.7 billion in revenue last year. Management believes these two medications can reach a higher combined peak than Humira.When the bull market finally arrives, AbbVie is a stock I would expect should be overdue for a big rally as investors are overlooking a solid business. With such a high yield, thanks in part to the modest price, the stock could be a great deal for investors today.2. NvidiaOne stock that has already begun to rally this year is Nvidia -- it's up 57% but still down around 20% from its high. The semiconductor stock has benefited from the growing popularity of artificial intelligence (AI) and chatbot ChatGPT. Its business could be fundamental in a shift to companies deploying more AI in their operations. A report from Bloomberg states that Microsoft used \"tens of thousands of Nvidia's A100 graphics chips\" to create a computer that would help OpenAI develop ChatGPT.While it's true that the PC market remains soft and that light demand in that area of its business may negatively affect Nvidia's growth in the near future, that shouldn't be a long-term concern; computers have finite lives and are due for routine upgrades.What's impressive is that even amid rising costs and headwinds in the tech sector, the company still reported a profit margin of 16% over the trailing 12 months, generating $4.4 billion in profit on sales of just under $27 billion; they were flat compared with the previous year. If that's an underwhelming stretch for Nvidia, I can't wait to see how well the business does when the bull market comes back, the economic outlook is stronger, and businesses are back to spending big money on tech and AI specifically.The stock's forward P/E multiple of 53 is steep, but Nvidia could still be a great buy, as the need for chips is only going to continue rising. And if Nvidia can maintain its strong profit margin, a lot of that incremental revenue growth will go to the bottom line and strengthen its earnings, making it look like a better buy in the process.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9943072736,"gmtCreate":1679009950626,"gmtModify":1679009953755,"author":{"id":"4087109808120260","authorId":"4087109808120260","name":"Tanyl","avatar":"https://static.tigerbbs.com/174329973340cf0f5b68791ee5b08afd","vip":1,"crmLevel":7,"crmLevelSwitch":1},"htmlText":"Must invest Nvidia&nbsp;","listText":"Must invest Nvidia&nbsp;","text":"Must invest Nvidia","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943072736","repostId":2319359390,"repostType":4,"repost":{"id":"2319359390","pubTimestamp":1678970199,"share":"https://www.laohu8.com/m/news/2319359390?lang=&edition=full","pubTime":"2023-03-16 20:36","market":"us","language":"en","title":"2 Growth Stocks to Buy Before the Bull Market Arrives","url":"https://stock-news.laohu8.com/highlight/detail?id=2319359390","media":"Motley Fool","summary":"Long-term investors shouldn't hesitate to add these stocks to their portfolios.","content":"<html><head></head><body><p>Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you&#39;ve found a good stock at a decent valuation, you shouldn&#39;t wait to buy it. Provided you&#39;re willing to buy and hold for years, now may be a good time to buy stocks while valuations are low.</p><p>A couple of stocks that look particularly good right now include <b>AbbVie </b>(ABBV 0.14%) and <b>Nvidia</b> (NVDA 0.69%). These businesses have promising growth potential, and adding either one of them to your portfolio today could be a great move.</p><h2>1. AbbVie</h2><p>Drugmaker AbbVie makes for both a solid growth stock and an income investment. At 4%, its dividend yield is more than twice the <b>S&amp;P 500</b> average of 1.7%. What makes it even more attractive is that it&#39;s also a Dividend King, with a track record for growing its dividend on a yearly basis. In just five years, its dividend payment has increased by 54%. The company&#39;s strong free cash flow and solid financials also suggest that more rate increases could be coming.</p><p><img src=\"https://static.tigerbbs.com/f42b6988b7c865a4e9bb99d564a85872\" tg-width=\"720\" tg-height=\"465\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Fundamental Chart data by YCharts</p><p>Over the past year, the healthcare stock has fluctuated and is up just a modest 2%. At a forward price-to-earnings (P/E) ratio of 14, which is based on analyst expectations, it&#39;s trading well below the S&amp;P 500 average of 18.</p><p>Investors have probably been discounting AbbVie as a result of the loss in patent protection for its top-selling drug, Humira, which has already begun. But the company&#39;s outlook and growth opportunities remain strong; AbbVie has more than 50 programs in its pipeline that are in mid- and late-stage trials that could help the company develop the next blockbuster drug. It has also been heavily investing in research and development, to the tune of $6.5 billion last year.</p><p>Plus, AbbVie already has a couple of promising immunology treatments with Skyrizi and Rinvoq, which earned a combined $7.7 billion in revenue last year. Management believes these two medications can reach a higher combined peak than Humira.</p><p>When the bull market finally arrives, AbbVie is a stock I would expect should be overdue for a big rally as investors are overlooking a solid business. With such a high yield, thanks in part to the modest price, the stock could be a great deal for investors today.</p><h2>2. Nvidia</h2><p>One stock that has already begun to rally this year is Nvidia -- it&#39;s up 57% but still down around 20% from its high. The semiconductor stock has benefited from the growing popularity of artificial intelligence (AI) and chatbot ChatGPT. Its business could be fundamental in a shift to companies deploying more AI in their operations. A report from <i>Bloomberg</i> states that <b>Microsoft </b>used &#34;tens of thousands of Nvidia&#39;s A100 graphics chips&#34; to create a computer that would help OpenAI develop ChatGPT.</p><p>While it&#39;s true that the PC market remains soft and that light demand in that area of its business may negatively affect Nvidia&#39;s growth in the near future, that shouldn&#39;t be a long-term concern; computers have finite lives and are due for routine upgrades.</p><p>What&#39;s impressive is that even amid rising costs and headwinds in the tech sector, the company still reported a profit margin of 16% over the trailing 12 months, generating $4.4 billion in profit on sales of just under $27 billion; they were flat compared with the previous year. If that&#39;s an underwhelming stretch for Nvidia, I can&#39;t wait to see how well the business does when the bull market comes back, the economic outlook is stronger, and businesses are back to spending big money on tech and AI specifically.</p><p>The stock&#39;s forward P/E multiple of 53 is steep, but Nvidia could still be a great buy, as the need for chips is only going to continue rising. And if Nvidia can maintain its strong profit margin, a lot of that incremental revenue growth will go to the bottom line and strengthen its earnings, making it look like a better buy in the process.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks to Buy Before the Bull Market Arrives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks to Buy Before the Bull Market Arrives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-03-16 20:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation...</p>\n\n<a href=\"https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","BK4023":"应用软件","BK4532":"文艺复兴科技持仓","BK4554":"元宇宙及AR概念","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU0056508442.USD":"贝莱德世界科技基金A2","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU0082616367.USD":"摩根大通美国科技A（dist）","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1712237335.SGD":"Natixis Mirova Global Sustainable Equity H-R-NPF/A SGD","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","ABBV":"艾伯维公司","SG9999002232.USD":"Allianz Global High Payout USD","LU0109392836.USD":"富兰克林科技股A","LU2063271972.USD":"富兰克林创新领域基金","SG9999002224.SGD":"Allianz Global High Payout SGD","NVDA":"英伟达","BK4587":"ChatGPT概念","LU0097036916.USD":"贝莱德美国增长A2 USD","BK4543":"AI","BK4527":"明星科技股","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU2326559502.SGD":"Natixis Loomis Sayles US Growth Equity P/A SGD-H","BK4579":"人工智能","BK4588":"碎股","BK4550":"红杉资本持仓","LU1861215975.USD":"贝莱德新一代科技基金 A2","LU0786609619.USD":"高盛全球千禧一代股票组合Acc","BK4503":"景林资产持仓","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","LU1861220033.SGD":"Blackrock Next Generation Technology A2 SGD-H","BK4551":"寇图资本持仓","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","BK4581":"高盛持仓","IE0009356076.USD":"JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION \"A2\" (USD) ACC","LU1316542783.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","BK4549":"软银资本持仓","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","BK4548":"巴美列捷福持仓","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU0109391861.USD":"富兰克林美国机遇基金A Acc","BK4529":"IDC概念","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU0642271901.SGD":"Janus Henderson Horizon Global Technology Leaders A2 SGD-H","LU1435385759.SGD":"Natixis Loomis Sayles US Growth Equity RA SGD-H","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC"},"source_url":"https://www.fool.com/investing/2023/03/16/2-growth-stocks-to-buy-before-bull-market-arrives/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2319359390","content_text":"Timing the market is a risky strategy. If you wait too long, you can miss the rally when it inevitably comes. Investors react quickly to news, and so if you've found a good stock at a decent valuation, you shouldn't wait to buy it. Provided you're willing to buy and hold for years, now may be a good time to buy stocks while valuations are low.A couple of stocks that look particularly good right now include AbbVie (ABBV 0.14%) and Nvidia (NVDA 0.69%). These businesses have promising growth potential, and adding either one of them to your portfolio today could be a great move.1. AbbVieDrugmaker AbbVie makes for both a solid growth stock and an income investment. At 4%, its dividend yield is more than twice the S&P 500 average of 1.7%. What makes it even more attractive is that it's also a Dividend King, with a track record for growing its dividend on a yearly basis. In just five years, its dividend payment has increased by 54%. The company's strong free cash flow and solid financials also suggest that more rate increases could be coming.Fundamental Chart data by YChartsOver the past year, the healthcare stock has fluctuated and is up just a modest 2%. At a forward price-to-earnings (P/E) ratio of 14, which is based on analyst expectations, it's trading well below the S&P 500 average of 18.Investors have probably been discounting AbbVie as a result of the loss in patent protection for its top-selling drug, Humira, which has already begun. But the company's outlook and growth opportunities remain strong; AbbVie has more than 50 programs in its pipeline that are in mid- and late-stage trials that could help the company develop the next blockbuster drug. It has also been heavily investing in research and development, to the tune of $6.5 billion last year.Plus, AbbVie already has a couple of promising immunology treatments with Skyrizi and Rinvoq, which earned a combined $7.7 billion in revenue last year. Management believes these two medications can reach a higher combined peak than Humira.When the bull market finally arrives, AbbVie is a stock I would expect should be overdue for a big rally as investors are overlooking a solid business. With such a high yield, thanks in part to the modest price, the stock could be a great deal for investors today.2. NvidiaOne stock that has already begun to rally this year is Nvidia -- it's up 57% but still down around 20% from its high. The semiconductor stock has benefited from the growing popularity of artificial intelligence (AI) and chatbot ChatGPT. Its business could be fundamental in a shift to companies deploying more AI in their operations. A report from Bloomberg states that Microsoft used \"tens of thousands of Nvidia's A100 graphics chips\" to create a computer that would help OpenAI develop ChatGPT.While it's true that the PC market remains soft and that light demand in that area of its business may negatively affect Nvidia's growth in the near future, that shouldn't be a long-term concern; computers have finite lives and are due for routine upgrades.What's impressive is that even amid rising costs and headwinds in the tech sector, the company still reported a profit margin of 16% over the trailing 12 months, generating $4.4 billion in profit on sales of just under $27 billion; they were flat compared with the previous year. If that's an underwhelming stretch for Nvidia, I can't wait to see how well the business does when the bull market comes back, the economic outlook is stronger, and businesses are back to spending big money on tech and AI specifically.The stock's forward P/E multiple of 53 is steep, but Nvidia could still be a great buy, as the need for chips is only going to continue rising. And if Nvidia can maintain its strong profit margin, a lot of that incremental revenue growth will go to the bottom line and strengthen its earnings, making it look like a better buy in the process.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":86,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}